资讯

Brainomix E-Lung Analysis Detects Treatment Effects in Phase 2a IPF Trial

unite.ai·2026/9/8 12:08:02🔗 原文

📋总体概括

Brainomix and Endeavor BioMedicines presented positive results on September 8, 2026, from an AI-driven quantitative analysis of CT imaging data collected in Endeavor's Phase 2a trial of taladegib in i

⚡关键信息

▸Brainomix and Endeavor BioMedicines presented positive resul

📰 相关资讯（与本文相关的其他资讯）

资讯阿斯麦赢得台积电和三星承诺新一代EUV光刻机获强力“护航”🔥9.0

财联社深度·2026/9/8

资讯存储芯片议价权生变：据称苹果罕见签下NAND长协，不设价格上限🔥9.0

财联社深度·2026/9/8

资讯CXMT and YMTC Stockpile ASML Tools for Three-Year Expansion Plans🔥9.0

TechPowerUp·2026/9/8

资讯三星电子、台积电确认分别于 2028、2030 年将 High NA EUV 用于量产🔥9.0

IT之家·2026/9/8

本文由本站自动聚合，以下为原始来源：前往 unite.ai 阅读全文 →

← 返回资讯流